EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Osteoporosis and FRAX risk in patients with liver cirrhosis

Azucena I. Casanova-Lara, Pilar A. Peniche-Moguel, José L. Pérez-Hernández, Eduardo Pérez-Torres, Galileo Escobedo González, Chantal J. Córdova-Gallardo

Revista Médica Del Hospital General De México · 2014

DOI: 10.1016/j.hgmx.2014.10.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Médica Del Hospital General De México, 2014. Verfasst von Azucena I. Casanova-Lara und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatic osteodystrophy is any bone disease in patients with chronic liver disease. To measure bone mineral density (BMD) T-score by bone densitometry (BD) is used, classifying the disease in osteopenia, osteoporosis and severe osteoporosis. There are not criteria for monitoring and detection of osteodystrophy in cases of non-cholestasic cirrhosis. To determine the risk of fracture at 10 years, Fracture Risk Assessment Tool (FRAX), could be useful.

Objectives

Determine the frequency of hepatic osteodystrophy in cirrhotic patients according to BD and FRAX and identify associated risk factors. Patients and methods: An observational, analytic, cross-sectional study. We included cirrhotic patients with report of DO and FRAX.

Results

52 patients were included, 38 were female (73.1%). The mean age was 12.29 ± 55.46 year-old, MELD 4.14 ± 11.71. In cholestatic etiology Mayo Score was 2.9 ± 3.31. The BMD was 0.756 ± 0.1896 mg/ cm 2 and T-score -2.34 ± 1.0. Of all patients, 26 (50%) had ranges of osteopenia and 21 (40.4%) of osteoporosis. Fracture risk with FRAX 10-year was 7.77 ± 6,713, and when we added the value of T-score fracture risk was 13.72 ± 12. Higher prevalence of cholestatic diseases in women and viral etiology in men (P = 0.006) was observed. There was significant relationship between cholestatic etiology T-score, alkaline phosphatase, and elderly and FRAXS with T-score (P =< 0.05). Vitamin D was lower in patients with cholestatic liver disease (P = 0.047) and a trend towards lower value of FRAX in patients with cholestatic liver disease was observed.

Conclusions

The frequency of osteoporosis or osteopenia is 90.4% in Mexican patients with liver cirrhosis of different etiologies. The decreased levels of bone alkaline phosphatase and 25-hydroxyvitamin-D were correlated with the risk of bone disease in patients with liver cirrhosis.

Zitieren

APA

Casanova-Lara, A. I., Peniche-Moguel, P. A., Pérez-Hernández, J. L., Pérez-Torres, E., González, G. E., & Córdova-Gallardo, C. J. (2014). Osteoporosis and FRAX risk in patients with liver cirrhosis. Revista Médica Del Hospital General De México. https://doi.org/10.1016/j.hgmx.2014.10.005

Vancouver

Casanova-Lara AI, Peniche-Moguel PA, Pérez-Hernández JL, Pérez-Torres E, González GE, Córdova-Gallardo CJ. Osteoporosis and FRAX risk in patients with liver cirrhosis. Revista Médica Del Hospital General De México. 2014. doi:10.1016/j.hgmx.2014.10.005

BibTeX
@article{CasanovaLara2014,
  author = {Casanova-Lara, Azucena I. and Peniche-Moguel, Pilar A. and Pérez-Hernández, José L. and Pérez-Torres, Eduardo and González, Galileo Escobedo and Córdova-Gallardo, Chantal J.},
  title = {Osteoporosis and FRAX risk in patients with liver cirrhosis},
  journal = {Revista Médica Del Hospital General De México},
  year = {2014},
  doi = {10.1016/j.hgmx.2014.10.005}
}
Kostenlos starten →